Lincoln Pharmaceuticals Ltd - LINCOLN PHARMA. Share Price

Sector: Pharmaceuticals | ISIN: INE405C01035
₹ 686.35 (-1.04%) icon21 Feb, 2024, 12:00:00 AM
Open
₹ 696.00
Prev. Close
₹ 693.55
Turnover(lac)
₹ 0.01
Day's High
₹ 701.65
Day's Low
₹ 680.15
52 Wk High
₹ 718.80
52 Wk Low
₹ 319.25
Book Value
₹ 288.16
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 1,374.74
P/E
15.75
EPS
43.57
Div. Yield
0.22

Lincoln Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/21/2024 12:00:00 AM

    ₹ 686.35 -7.20 -1.04
  • Open
  • ₹ 696
  • Prev. Close
  • ₹ 693.55
  • Turnover(Lac.)
  • ₹ 1,152
  • Day's High
  • ₹ 701.65
  • Day's Low
  • ₹ 680.15
  • 52 Week's High
  • ₹ 718.8
  • 52 Week's Low
  • ₹ 319.25
  • Book Value
  • ₹ 288.16
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 1,374.74
  • P/E
  • 15.75
  • EPS
  • 43.57
  • Divi. Yield
  • 0.22

Lincoln Pharmaceuticals Ltd Corporate Actions

25 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2024

12:00 AM

23 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Oct , 2023

12:00 AM

26 Aug , 2023

12:00 AM

AGM

Announcement date: 26 Aug , 2023

View Details

25 May , 2023

12:00 AM

Dividend

Dividend amount: 1.5
Announcement date: 25 May , 2023

View Details

28 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

15 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Aug , 2023

12:00 AM

BookCloser

View Details

Lincoln Pharmaceuticals Ltd News and Update

Image not found
  • 16 February, 2024 |
  • 11:57 PM

Recommendation: Buy; Target price: ₹581

Article Image
Image not found
  • IIFL News Service |
  • 14 February, 2024 |
  • 11:54 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Lincoln Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
21 February , 2024 | 08:16 PM

PROMOTER - TOTAL49.80%

Indian: 49.80%

Foreign: 0%

NON-PROMOTER - TOTAL 50.20%

Institutions: 3.29%

Non-Institutions: 46.91%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Lincoln Pharmaceuticals Ltd FINANCIALS

Lincoln Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Lincoln Pharmaceuticals Ltd

  • Kishorbhai M Shah
  • Chairman (Non-Executive)
  • Mahendra G Patel
  • Managing Director
  • Hasmukhbhai I Patel
  • Whole-time Director
  • Pirabhai R Suthar
  • Independent Director
  • Munjal Mahendrabhai Patel
  • Whole-time Director
  • Aashish R Patel
  • Whole-time Director
  • Meha Patel
  • Independent Director
  • Saurin J Parikh
  • Independent Director
  • Rajnikant G Patel
  • Director
  • Anand Arvindbhai Patel
  • Whole-time Director
  • Trusha Shah
  • Company Sec. & Compli. Officer

Summary

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. 95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.96 to part-finance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 2021-22, Lincoln Parenteral Limited (Transferor Company), an... Read More


Reports by Lincoln Pharmaceuticals Ltd


Reports by Lincoln Pharmaceuticals Ltd

Company FAQ

No Record Found